{
    "2019-08-21": [
        [
            {
                "time": "",
                "original_text": "药企半年报：药明康德CRO增104%，石药创新药销售超60亿",
                "features": {
                    "keywords": [
                        "药明康德",
                        "CRO",
                        "增长",
                        "石药",
                        "创新药",
                        "销售"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德：各板块增长强劲 买入评级",
                "features": {
                    "keywords": [
                        "药明康德",
                        "板块",
                        "增长",
                        "买入评级"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "里昂：升药明康德(2359.HK)目标价至98.84港元 经调整纯利润略胜预期",
                "features": {
                    "keywords": [
                        "药明康德",
                        "目标价",
                        "上调",
                        "纯利润",
                        "预期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【权益变动】药明康德(02359-HK)被高盛减持44.24万股 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "高盛",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "上调评级至买入策略选股（8月21日）",
                "features": {
                    "keywords": [
                        "上调评级",
                        "买入策略",
                        "选股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中报五大看点：25股净利增超300% 18股二季度环比猛增10倍+",
                "features": {
                    "keywords": [
                        "中报",
                        "净利",
                        "增长",
                        "环比",
                        "猛增"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药明康德:收入高速增长,各板块增长强劲",
                "features": {
                    "keywords": [
                        "药明康德",
                        "收入",
                        "增长",
                        "板块"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}